BRIEF published on 09/29/2026 at 10:05, 24 days 4 hours ago Cyprumed's Oral Delivery Technology Enters Clinical Phase with MSD Trial Clinical Development Phase I Trial Cyprumed Oral Delivery Technology MSD Collaboration
BRIEF published on 09/29/2026 at 10:05, 24 days 4 hours ago La technologie d'administration orale de Cyprumed entre en phase clinique avec un essai mené par MSD. Développement Clinique Essai De Phase I Cyprumed Technologie D'administration Orale Collaboration MSD
PRESS RELEASE published on 09/29/2026 at 10:00, 24 days 5 hours ago Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial Cyprumed's oral delivery technology advances to clinical stage as MSD initiates Phase I trial, marking a significant milestone in drug development Phase I Trial Clinical Stage Cyprumed MSD Oral Delivery Technology
BRIEF published on 04/15/2025 at 09:05, 1 year 6 months ago Cyprumed Partners with MSD on Oral Peptide Therapeutics Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
BRIEF published on 04/15/2025 at 09:05, 1 year 6 months ago Cyprumed s'associe à MSD pour développer des thérapies peptidiques orales Technologie D'administration De Médicaments Accord De Licence Cyprumé Partenariat MSD Thérapies Peptidiques Orales
PRESS RELEASE published on 04/15/2025 at 09:00, 1 year 6 months ago Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
Published on 10/23/2026 at 13:23, 1 hour 39 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 2 hours 2 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 2 hours 2 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 12 hours 42 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 15 hours 32 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/23/2026 at 14:55, 7 minutes ago Canadian Molly Carlson Becomes First Woman to Dive off a Free-Standing Iceberg in Newfoundland
Published on 10/23/2026 at 14:25, 37 minutes ago Vantage Enhances Its V-Card Premium Payment Experience for CFD Traders
Published on 10/23/2026 at 14:00, 1 hour 2 minutes ago Alzchem again ranked among the top 5% of companies rated worldwide by EcoVadis
Published on 10/23/2026 at 13:25, 1 hour 37 minutes ago India's Spiritual Leadership Takes Center Stage Globally: *H.H. Shree Shivkrupanand Swami, promoter of global spritual platform 'Gurutattva' and 'Himalayan Samarpan Meditation', appointed Vice Chair of 'World Meditation Day Governance Committee'
Published on 10/23/2026 at 12:54, 2 hours 7 minutes ago EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re reports quarterly net profit of €1.7bn and raises full-year guidance
Published on 10/23/2026 at 07:00, 8 hours 2 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 21 hours 2 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 21 hours 2 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 21 hours 2 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
